Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oromag 160 tablets
0101010I0BEABAL
|
Oromag 160 | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Orphacol 250mg capsules
0109010H0BBABAE
|
Orphacol | Cholic acid | Gastro-Intestinal System | No data available |
|
Orphacol 50mg capsules
0109010H0BBAAAI
|
Orphacol | Cholic acid | Gastro-Intestinal System | No data available |
|
OTC Concepts Liquid Laxative 5mg/5ml oral solution
0106020P0BEAAAB
|
OTC Concepts | Sodium picosulfate | Gastro-Intestinal System | No data available |
|
Otulfi 130mg/26ml concentrate for inf vials
0105030B0BGAAAA
|
Otulfi | Ustekinumab | Gastro-Intestinal System | No data available |
|
Oximag 100mg capsules
0101010I0BGAAAB
|
Oximag | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Pancrease gastro-resistant capsules
0109040N0BFAAAN
|
Pancrease | Pancreatin | Gastro-Intestinal System | No data available |
|
Pancreaze Delayed-Release capsules
0109040N0BGAABA
|
Pancreaze | Pancreatin | Gastro-Intestinal System | No data available |
|
Pancreolan Forte 6000 gastro-resistant tablets
0109040N0BIAABD
|
Pancreolan | Pancreatin | Gastro-Intestinal System | No data available |
|
Pantoloc Control 20mg gastro-resistant tablets
0103050R0BCAAAB
|
Pantoloc | Pantoprazole | Gastro-Intestinal System | No data available |
|
Pantoprazole 20mg/5ml oral suspension
0103050R0AAAEAE
|
Pantoprazole | Pantoprazole | Gastro-Intestinal System | No data available |
|
Pantoprazole 40mg/5ml oral suspension
0103050R0AAAFAF
|
Pantoprazole | Pantoprazole | Gastro-Intestinal System | No data available |
|
Pectigel powder
010401000BBATA0
|
Proprietary compound preparation BNF 0104010 | Other adsorbent and bulk-forming preparations | Gastro-Intestinal System | No data available |
|
Pepcid 20mg tablets
0103010H0BBAAAA
|
Pepcid | Famotidine | Gastro-Intestinal System | No data available |
|
Pepcid 40mg tablets
0103010H0BBABAB
|
Pepcid | Famotidine | Gastro-Intestinal System | No data available |
|
Pepcid AC Indigestion 10mg tablets
0103010H0BBACAC
|
Pepcid | Famotidine | Gastro-Intestinal System | No data available |
|
Pepcidtwo chewable tablets
010102100BBAKA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Peptimax 200 tablets
0103010D0BDAAAA
|
Peptimax | Cimetidine | Gastro-Intestinal System | No data available |
|
Peptimax 400 tablets
0103010D0BDABAB
|
Peptimax | Cimetidine | Gastro-Intestinal System | No data available |
|
Phenolphthalein yellow 120mg / Rhubarb 27.5mg tablets
0106020U0AAAAAA
|
Phenolphthalein/rhubarb | Phenolphthalein and rhubarb | Gastro-Intestinal System | No data available |
|
Phillips' Milk of Magnesia 300mg chewable tablets
0101010Q0BDAFAB
|
Milk of Magnesia (Omega/SmithKline) | Magnesium hydroxide | Gastro-Intestinal System | No data available |
|
Pirenzepine 100mg tablets
0103020P0AAACAC
|
Pirenzepine | Pirenzepine | Gastro-Intestinal System | No data available |
|
Pirenzepine 25mg tablets
0103020P0AAABAB
|
Pirenzepine | Pirenzepine | Gastro-Intestinal System | No data available |
|
Potter's Senna 7.5mg tablets 12 Years Plus
0106020M0BGADAC
|
Potter's Senna | Senna | Gastro-Intestinal System | No data available |
|
Predenema 20mg/100ml long tube
0105020D0BBAAAA
|
Predenema | Prednisolone sodium metasulphobenzoate | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.